Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ADAP - Adaptimmune Therapeutics plc
Market Cap 198.27M P/E - EPS this Y 11.10% Ern Qtrly Grth -
Income -163.41M Forward P/E -1.63 EPS next Y 6.20% 50D Avg Chg -11.00%
Sales 18.36M PEG -2.71 EPS past 5Y - 200D Avg Chg -38.00%
Dividend N/A Price/Book 1.74 EPS next 5Y 1.00% 52W High Chg -67.00%
Recommedations 2.40 Quick Ratio 2.60 Shares Outstanding 255.56M 52W Low Chg 1.00%
Insider Own 0.39% ROA -44.57% Shares Float 1.02B Beta 2.30
Inst Own 64.40% ROE -301.91% Shares Shorted/Prior 6.30M/4.90M Price 0.88
Gross Margin - Profit Margin - Avg. Volume 892,806 Target Price 2.08
Oper. Margin -867.58% Earnings Date Aug 7 Volume 380,104 Change -3.06%
Healthcare | Biotechnology | United Kingdom
About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; research, collaboration, and license agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Adaptimmune Therapeutics plc News
07/24/24 Why Are Hedge Funds Bullish on Adaptimmune Therapeutics plc (ADAP) Now?
07/03/24 3 Biotech Moonshots With Imminent Catalyst Potential
07/03/24 5 FDA decisions to watch in the third quarter
07/02/24 Fireside Chat with Adrian Rawcliffe, Chief Executive Officer of Adaptimmune
06/12/24 ADAP: Initiating Coverage of Adaptimmune, a Leading T-Cell Therapy Company
06/03/24 Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise
05/30/24 Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications
05/15/24 Adaptimmune Reports Q1 2024 Financial and Business Updates
05/15/24 Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital
05/01/24 Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
04/15/24 Adaptimmune (ADAP) Down on End of Collaboration With Roche
04/12/24 Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
04/12/24 Roche, Adaptimmune part ways on cell therapy research
06:30 PM Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet
03/08/24 Adaptimmune Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
03/07/24 Adaptimmune Therapeutics PLC Reports Q4 and Full Year 2023 Financial Results
03/07/24 Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript
03/06/24 Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates
08:00 AM Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
02/21/24 Adaptimmune to Report Q4 and Full Year 2023 Financial and Business Updates on Wednesday, March 6, 2024
ADAP Chatroom

User Image MarcusEpi Posted - 4 hours ago

$ADAP pile of shit lol so 100m revenue on this approval? big whoop

User Image Steadynwise Posted - 5 hours ago

$ADAP 14 hedge fund investors, PT $4.29 https://finance.yahoo.com/news/why-hedge-funds-bullish-adaptimmune-031319245.html

User Image Aamadeus Posted - 9 hours ago

$ADAP I like it. Hopefully 1.6 next week…

User Image GrandPoobahofBagholders Posted - 10 hours ago

$ADAP Signs of life! Hopefully see $1.50+ next week!

User Image DebWater_ Posted - 10 hours ago

$ADAP Good to see progress.

User Image Gamer001 Posted - 11 hours ago

$ADAP looking for $2 breakout next Monday

User Image Winner_Chicken_Dinner Posted - 11 hours ago

$ADAP I'll take it👊

User Image CliffordCapital Posted - 11 hours ago

$ADAP MONDAY OPEN 1.50$ + 🔥🔥

User Image ians Posted - 11 hours ago

$ADAP Warming up its boosters🚀 $2+ looks probable. 👍 $3-5 LT PT☘️💎

User Image MKRReformed Posted - 11 hours ago

$ADAP ez pz

User Image RagingBullTime Posted - 11 hours ago

$ADAP I believe that God is just. I believe that we deserve to see $4 + soon.

User Image bestdriver7 Posted - 12 hours ago

$ADAP

User Image Bionco Posted - 12 hours ago

$ADAP hopefully we can close @ around $1.40

User Image FringDook Posted - 12 hours ago

$ADAP Adaptimmune to the moon 🚀 🌙

User Image HarveySpecter20 Posted - 12 hours ago

$ADAP

User Image TheBiotechInvestor_ Posted - 12 hours ago

$ADAP let’s gooooo

User Image TimingTimingTiming Posted - 14 hours ago

$ADAP way too many flippers here this is going to fall on approval

User Image Night2 Posted - 15 hours ago

$ADAP Aug 8 beat

User Image Slambucket Posted - 15 hours ago

$ADAP - what’s with the supply at 1.36?

User Image Runmaster83 Posted - 15 hours ago

$ADAP Sold and took profit from $1.15 avg. If I didn’t need money, I would have stayed put. Good investment long-term here imo….Damn house repairs! 🏡 GLTA

User Image CliffordCapital Posted - 16 hours ago

$ADAP GIVE US A 1.40$ CLOSE AND MONDAY OPEN IN THE 50’s! ⚡️🔥🔥

User Image MKRReformed Posted - 16 hours ago

$ACET 1.22-1.26 LOAD* mention just hit 1.59. $adap also up 17% from initial entry mention both with 8-10%+ dip re add mentions 🫡

User Image Polip Posted - 16 hours ago

$ADAP holding strong and breakout pattern confirmed!

User Image BowernTrumpl Posted - 16 hours ago

$ADAP 🔥

User Image MKRReformed Posted - 17 hours ago

$ADAP love how this ticker moves

User Image Ruzmadji Posted - 17 hours ago

$GERN $UNCY $ADAP They are Printing More Money for Me! LMAO

User Image dhovekamp42 Posted - 17 hours ago

as of Jul 25, 2024 04:00 pm ET $ADAP at $1.30 $NVDA at $115

User Image mmtiddy Posted - 18 hours ago

$ADAP To any bears mentioning dilution scare tactics - it wont work. From their earnings report in Q1 2024

User Image CliffordCapital Posted - 18 hours ago

$ADAP 1.80$

User Image FringDook Posted - 19 hours ago

$ADAP

Analyst Ratings
Scotiabank Sector Outperform May 30, 24
Mizuho Buy May 17, 24
Barclays Underweight Aug 10, 23
EF Hutton Buy Aug 10, 23
EF Hutton Buy Jun 5, 23
EF Hutton Buy Jun 2, 23
EF Hutton Buy May 26, 23
EF Hutton Buy Apr 17, 23
EF Hutton Buy Apr 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 16 Sell 0.73 39,384 28,750 44,848 01/17/24
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 16 Sell 0.71 20,563 14,600 19,257 01/17/24
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 16 Sell 0.71 22,795 16,184 19,015 01/17/24
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 16 Sell 0.71 23,589 16,748 20,201 01/17/24
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 11 Sell 0.85 11,808 10,037 11,841 01/12/24
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 11 Sell 0.85 9,229 7,845 7,874 01/12/24
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 0.85 29,202 24,822 26,388 01/12/24
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 11 Sell 0.85 9,229 7,845 7,874 01/12/24
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Sep 01 Sell 0.78 2,403 1,874 3,449 09/01/23
Menzel Garry E Director Director Jul 10 Sell 0.9108 47,702 43,447 75,056 07/10/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jun 27 Sell 0.92 2,333 2,146 3,519 06/27/23
Piccina Cintia Chief Commercial Off.. Chief Commercial Officer Jan 31 Sell 1.8696 11,890 22,230 19,535 01/31/23
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 17 Sell 1.858 4,440 8,250 7,264 01/17/23
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 17 Sell 1.858 4,440 8,250 7,264 01/17/23
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 17 Sell 1.858 2,159 4,011 3,491 01/17/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 17 Sell 1.858 10,057 18,686 13,351 01/17/23
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 11 Sell 1.73 8,816 15,252 8,121 01/12/23
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 11 Sell 1.73 8,816 15,252 8,121 01/12/23
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 11 Sell 1.73 11,292 19,535 12,191 01/12/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 1.73 31,805 55,023 24,882 01/12/23
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 04 Sell 1.694 3,584 6,071 5,781 01/04/23
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 04 Sell 1.6940 1,100 1,863 1,725 01/04/23
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 04 Sell 1.6940 876 1,484 1,361 01/04/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 04 Sell 1.6940 5,073 8,594 6,631 01/04/23
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Sep 01 Sell 1.9689 2,536 4,993 3,316 09/01/22
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Aug 01 Sell 1.7735 2,983 5,290 4,829 08/01/22
Piccina Cintia Chief Commercial Off.. Chief Commercial Officer Aug 01 Sell 1.7735 21,040 37,314 34,824 08/01/22
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jul 05 Sell 1.6781 1,973 3,311 3,104 07/05/22
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jun 27 Sell 1.63 2,562 4,176 3,290 06/27/22
Wood Gavin Chief Financial Offi.. Chief Financial Officer May 20 Buy 0.2904 39,000 11,326 96,000 05/23/22
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 18 Sell 3.1918 4,368 13,942 7,336 01/18/22
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 18 Sell 3.1918 4,368 13,942 7,336 01/18/22
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 18 Sell 3.1918 2,121 6,770 3,529 01/18/22
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 18 Sell 3.1918 11,096 35,416 12,312 01/18/22
Bertrand William C JR Chief Operating Offi.. Chief Operating Officer Jan 11 Sell 3.55 6,018 21,364 3,754 01/13/22
Lunger John Chief Patient Supply.. Chief Patient Supply Officer Jan 11 Sell 3.55 4,846 17,203 1,749 01/13/22
Norry Elliot Chief Medical Office.. Chief Medical Officer Jan 11 Sell 3.55 4,624 16,415 1,383 01/13/22
Rawcliffe Adrian Chief Executive Offi.. Chief Executive Officer Jan 11 Sell 3.55 17,408 61,798 3,356 01/13/22